Surmodics | SRDX - Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 14.16M 2026-03
Anika Therapeutics USD 20.97M 942K 2026-03
Arrowhead Research USD 295.22M 52.2M 2026-03
Artivion USD 92.7M 8.86M 2026-03
Baxter International USD 3.69B 723M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
EDAP TMS EUR 31.4M 2.71M 2025-09
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Haemonetics USD 282.6M 257.27M 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
J&J USD 57.72B 3.59B 2026-03
Merit Medical Systems USD 216.87M 22.89M 2026-03
Mesa Laboratories USD 54.4M 6.1M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Option Care Health USD 729.74M 99.6M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Surmodics USD 19.44M 1.1M 2025-06
Trinity Biotech USD 34.49M 2.97M 2025-09